Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Tony Daltorio

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Two of my favorite stocks remain Eli Lilly & Company (LLY) and Novo Nordisk A/S (NVO), thanks to their GLP-1 weight loss drugs. Today, I want to draw your attention in particular to Nordisk, which reported results on Jan. 31.

NVO shares have been hitting record highs, as the Danish pharma company’s blockbuster weight-loss drugs drove a massive surge in sales and profits last year. Novo Nordisk reported that sales climbed 36% to $33.7 billion in 2023, while profits rose to $12.14 billion, or $2.70 per share.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.